NIFTY 5022,302.50
0.00 (0.00%)
SENSEX▼73,466.39
-45.46 (-0.06%)
NIFTY BANK▼48,021.10
-264.25 (-0.55%)
TATA MOTORS▲1,012.10
23.55 (2.38%)
INDIAN RAILWAY FINANCE CORP▲152.25
2.45 (1.64%)
TATA POWER▼435.05
-1.35 (-0.31%)
TATA STEEL▲166.05
1.80 (1.10%)
SUZLON ENERGY▲39.95
0.20 (0.50%)
YES BANK▲22.95
0.10 (0.44%)
INDIAN RENEWABLE ENERGY▲170.90
3.20 (1.91%)
RELIANCE INDUSTRIES▲2,837.10
34.15 (1.22%)
VODAFONE IDEA▲12.70
0.30 (2.42%)
RELIANCE POWER▲25.75
0.10 (0.39%)
JIO FIN SERVICES LTD▼355.20
-1.05 (-0.29%)
HDFC BANK▼1,482.65
-23.50 (-1.56%)
RAIL VIKAS NIGAM▲269.95
3.10 (1.16%)
ADANI POWER▲580.65
0.10 (0.02%)
ZOMATO▲195.45
4.00 (2.09%)
NHPC▲98.85
1.75 (1.80%)
STATE BANK OF INDIA▲810.80
8.90 (1.11%)
INDIAN OIL CORP▲163.15
3.15 (1.97%)
INDIAN RAILWAY TOURISM CORP▲1,007.45
13.95 (1.40%)
MRF▲1,26,677.65
2163.15 (1.74%)
ITC▲441.00
0.65 (0.15%)
JAIPRAKASH POWER VENTURES▲18.60
0.15 (0.81%)
ADANI GREEN ENERGY▲1,773.00
47.00 (2.72%)
ADANI PORT & SEZ▼1,277.25
-10.40 (-0.81%)
ADANI ENTERPRISES▲2,860.55
24.60 (0.87%)
- TRANSGENE BIOTEK LTD
TRANSGENE BIOTEK LTD Share Price
TRABI
₹6.85-₹0.15 (-2.14%) TodayLast updated on 08 May, 2024 | 03:29 PM IST
₹6.80₹7.29
LH
What’s in news?
No data available at the moment
Company overview
About
Market cap
| Open₹7.29 | Close₹7.00 |
Circuit range₹7.35 - ₹6.65 | Day range₹6.80 - ₹7.29 | Year range₹2.94 - ₹12.46 |
Volume66,808 | Avg. traded₹6.89 | Revenue (12m)₹0 Cr |
TRANSGENE BIOTEK LTDTransgene Biotek Limited is an India-based biotechnology company. The Company is engaged in the research and development of vaccines, oncology and new drug delivery technologies. Its portfolio of products includes oncology, auto-immunity, drug delivery and biogenerics. The Company offers TrabiAAV, which is a platform for the delivery of micro ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy and CRISPR/cas 9 technologies. Its monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL is focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-1203, is used to strengthen cell-mediated immunity and complete elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus is a drug that suppresses the immune system and is mainly used to prevent rejection of transplanted organs.
Read more
TRANSGENE BIOTEK LTD Key indicators
52 week high₹12.46 | 52 week low₹2.94 | P/E ratio |
P/B ratio4.89 | ROE-- | ROCE-57.49% |
Dividend yield-- | Debt/Equity ratio-2.11 | EPS-0.79 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin-789.22% | Net profit margin0% |
ROE0% | ROA-17.24% |
ROCE-57.49% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
TRANSGENE BIOTEK LTD Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Tue, May 7 2024 | ₹7.08 | ₹7.00 | -1.14% |
Mon, May 6 2024 | ₹7.24 | ₹7.04 | -2.84% |
Fri, May 3 2024 | ₹7.17 | ₹7.24 | |
Thu, May 2 2024 | ₹7.11 | ₹7.07 | -0.57% |
Tue, Apr 30 2024 | ₹7.37 | ₹7.08 | -4.10% |
Mon, Apr 29 2024 | ₹7.20 | ₹7.36 | |
Fri, Apr 26 2024 | ₹7.56 | ₹7.12 | -6.18% |
Thu, Apr 25 2024 | ₹7.70 | ₹7.48 | -2.94% |
Events
No data available at the moment